Table 1.
Participant demographics, body mass, fluid intake and marathon time data
| Complete finish line cohort (n=28) |
NSAID group (n=16) |
Control group (n=12) |
P value* | |
| Age (years) | 45±9 | 43±8 | 47±11 | 0.316 |
| Male:female | 21:7 | 10:6 | 11:1 | 0.058 |
| Body mass (kg) | 79.0±16.8 | 77.8±18.8 | 80.8±14.4 | 0.649 |
| Caucasian ethnicity, n (%) | 23 (82.1) | 13 (81.2) | 12 (100) | 0.112 |
| Number of prior marathons completed | 6±13 | 4±10 | 7±16 | 0.532 |
| Estimated fluid intake during the marathon (L) | 1.4±1.5 | 1.7±1.6 | 1.0±1.5 | 0.309 |
| Race time (min) | 276.0±48.0 | 276.8±45.6 | 281.0±58.7 | 0.834 |
| Absolute body mass change (kg) | −1.6±1.3 | −1.4±1.3 | −1.9±1.2 | 0.376 |
| Relative body mass change (%) | −2.1±1.5 | −1.9±1.6 | −2.3±1.4 | 0.568 |
*P values are given for analysis between the NSAID and control groups. NSAID, non-steroidal anti-inflammatory medications.